Please see Dyadic’s YouTube Channel for more Videos
| Dyadic and VTT Are Developing an Efficient New Production Method for Covid-19 Vaccines - September 2020 |
| A Brief Look into Dyadic's Past and What the Future May Bring - September, 2020 |
| Noble Capital Markets
Channelcheck c-suite series One-on-one with President & CEO Mark Emalfarb - June 24, 2020 |
| Dyadic working with global research partners to express potential coronavirus vaccines using C1, May 15, 2020 |
| Planet MicroCap Showcase 2020 Panel Discussion on Coronavirus Pandemic |
| Ping Rawson, CFO invited guest with MSQ Ventures - Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges & Opportunities
February 27, 2020 |
| Trish Regan Primetime. Fox Business - Dyadic International (Nasdaq:DYAI) CEO Mark Emalfarb discusses how his company could expedite the production of an affordable coronavirus vaccine. |
| Mark Emalfarb, CEO (Nasdaq:DYAI) on YAHOO Finance On The Move to discuss the spread of Coronavirus February 4, 2020 |
| Mark Emalfarb / TD Ameritrade Interview “The Watch List” February 11, 2020 |
| #TradeTalks: Getting Ahead of the Curve on Pandemic & Biological Threats with Synthetic Biology February 2020 |
| Dyadic Getting Ahead of the Curve on Coronavirus Cure, CEO Says January 31, 2020 |
| Dyadic CEO Mark Emalfarb interviewed by Liz Claman “The Claman Countdown” from FOX Business Network - Monday, January 27, 2020 |
| Dyadic CEO remarks on steps the federal gov't can take to speed along drug manufacturing January 2020 |
| Dyadic International reveals recent 4Q highlights and upcoming milestones January 2020 |
| Dyadic International, Inc. (OTCQX: DYAI) The Innovation Show – August 2017 | From Stonewashed Jeans to Lifesaving Genes |
| Dyadic Seeks to Bring Disruptive Technology to Biomanufacturing, The Bio Report, June 2017 |
